✅Fem-tech, AI in Mental Health on Investor Radar Next Year
The fem-tech sector focuses on meeting women’s healthcare needs and is projected to reach $60 billion in the next four years. And, artificial intelligence is being integrated into digital mental health services to address the shortage of mental health professionals.
Healthcare facing disruption with virtual visits, demand for rapid access to patient data, and the rise of AI. Managing this data influx requires extensive collaboration, often involving external entities like labs and physicians, handling a multifaceted challenge for the industry.
✅Pharma’s path to Net Zero: Targeting Scope 3 emissions
With a target of net zero for 2050, pharmaceutical companies need to tackle Scope 3 emissions that generate the majority of their carbon footprint. Scope 3 emissions encompass raw material production, distribution, product use, and end-of-life disposal, making them a complex part of the industry’s carbon footprint.